Analysts expect Amylyx Pharmaceuticals to post earnings of ($0.3609) per share for the quarter. Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. On average, analysts expect Amylyx Pharmaceuticals to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year. Get Amylyx Pharmaceuticals alerts:Amylyx Pharmaceuticals Stock Up 8.1%Shares of NASDAQ:AMLX opened at $21.81 on Wednesday. Amylyx Pharmaceuticals Company Profile(Get Free Report)Amylyx Pharmaceuticals, Inc is a biopharmaceutical company dedicated to developing treatments for rare and debilitating neurological diseases.